Supplementary Figure 7 from A687V EZH2 Is a Driver of Histone H3 Lysine 27 (H3K27) Hypertrimethylation
Heidi M. Ott(GlaxoSmithKline (United Kingdom)), Michael T. McCabe(GlaxoSmithKline (United States)), Yong Jiang(Leibniz-Institut für Pflanzengenetik und Kulturpflanzenforschung (IPK)), Dashyant Dhanak(Wilmington University), Alan P. Graves(GlaxoSmithKline (United States)), Edward Dul(GlaxoSmithKline (United States)), Steven D. Knight(GlaxoSmithKline (United States)), Wendy S. Halsey(GlaxoSmithKline (United States)), Sharad K. Verma(GlaxoSmithKline (United States)), Melissa B. Pappalardi(GlaxoSmithKline (United States)), Michael J. Huddleston(GlaxoSmithKline (United States)), Peter J. Tummino(Intarcia Therapeutics (United States)), Ashley M. Hughes(GlaxoSmithKline (United States)), Ryan G. Kruger(Arysta LifeScience (France)), Caretha L. Creasy, Yuchen Bai(China Agricultural University), Arthur Groy(GlaxoSmithKline (United States)), Benjamin Schwartz, Roland S. Annan(GlaxoSmithKline (United Kingdom))
Cited by 0
Related Papers
Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
|Nature|1999|1.9k
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
|Nature|2012|1.8k
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
|Journal of Biological Chemistry|2002|1.4k
The promise and peril of chemical probes
|Nature Chemical Biology|2015|848